2017 Subject Index
Abnormal head position................................................... 211
Acute retinal necrosis......................................................... 174
Aflibercept........................................................................... 133
Age.......................................................................................... 80
Age-related macular degeneration.......................... 205,355
Alpha1 blocker................................................................... 186
Amblyopia....................................................................... 28,74
Anisometropia................................................................. 28,74
Anterior ischemic optic neuropathy................................ 267
Anterior segment..................................................... 5,130,186
Anterior segment ischemia.................................................. 47
Anterior uveitis.................................................................... 110
Anti tubercular therapy....................................................... 89
Anti-vascular endothelial growth factor........................ 331
Atypical hemolytic uremic syndrome............................ 348
Bacterial keratiti................................................................. 161
Behçet’s uveitis................................................................... 261
Bevacizumab...................................................................... 144
Biofilm.................................................................................... 68
Blepharoptosis.................................................................... 235
Blindness........................................................................ 18,216
Capsular biocompatibility................................................ 221
Capsule contraction syndrome........................................ 106
Capsule tension ring........................................................... 106
Carbonic anhydrase I.......................................................... 85
Carbonic anhydrase II........................................................ 85
Carotid artery disease........................................................ 326
Carotid artery stenosis....................................................... 192
Cat scratch disease................................................................. 9
Cataract surgery................................................................. 221
Cell phone............................................................................ 130
Central corneal thickness.............................................. 1,133
Central serous chorioretinopathy.................................... 238
Choroidal neovascularization.................................. 115,243
Choroidal osteoma............................................................ 243
Choroidal-retinal thickness............................................... 315
Chronic conjunctivitis....................................................... 226
Clinical studies.................................................................... 338
Coherence............................................................................ 231
Color Doppler ultrasound................................................. 192
Contrast sensitivity.......................................................... 7480
Conventional lasers.............................................................. 34
Cornea.................................................................................. 292
Cornea endothelial cell density........................................ 255
Corneal aberrations........................................................... 249
Corneal collagen crosslinking........................................... 161
Corneal densitometry........................................................ 125
Corneal thickness......................................................... 24,315
Corneal tomography................................................. 125,255
Corticosteroid...................................................................... 238
Crystalline keratopathy.................................................... 344
Cultured cells....................................................................... 285
Cystinosis............................................................................. 292
Decompression surgery........................................................ 94
Deep anterior lamellar keratoplasty.................................. 63
Descemet’s membrane........................................................ 63
Dexamethasone......................................................... 156,274
Diabetes mellitus................................................................... 85
Diabetic................................................................................ 274
Diabetic macular edema................................................... 156
Diabetic retinopathy............................................................ 85........
Diabetic retinopathy treatment.......................................... 34
Diagnosis................................................................................ 59
Dissociated optic nerve fiber layer.................................. 138
Diving................................................................................... 296
Dry ey..................................................................................... 24
Eccrine.................................................................................. 113
Eculizumab......................................................................... 348
Endemic area...................................................................... 169
Endophthalmitis...................................................................... 9
Experimental cataract....................................................... 309
Eyelid lesions....................................................................... 226
Eyelid malposition............................................................. 149
Facial paralysis................................................................... 149
Fixed combination antiglaucoma medications............ 198
Fluocinolone acetonide..................................................... 156
Fluorescein angiography................................................... 298
Foster...................................................................................... 47
Foveal hypoplasia.............................................................. 306
Fundus autofluorescence.................................................. 306
Fundus autofluorescence imaging.................................. 298
Fungal keratitis, dry eyes.................................................. 344
Ganglion cell-inner plexiform layer................................. 138
Gene therapy....................................................................... 338
Glaucoma.................................................................... 119,267
Gold weight.......................................................................... 149
Goldmann applanation tonometry..................................... 1
Gonioscopy.............................................................................. 5
Graft-versus-Host disease................................................. 344
Graves’ orbitopathy............................................................. 42
Hereditary retinal dystrophy............................................ 302
Hereditary retinal dystrophies.......................................... 338
Hidrocystoma..................................................................... 113
High myopia....................................................................... 351
Histoplasmosis.................................................................... 115
Hodgkin’s lymphoma....................................................... 110
Hydrophilic............................................................................ 68
Hydrophilic acrylic intraocular lens................................ 221
Imaging................................................................................ 130
Immunomodulatory treatment......................................... 89
Implant................................................................................ 274
Intraocular foreign body..................................................... 52
Intraocular inflammation................................................... 52
Intraocular lenses................................................................. 68
Intraocular lens dislocation.............................................. 106
Intraocular pressure........................................................... 192
Intraocular pressure reduction rate................................. 198
Intravenous lipid solution................................................. 320
Intravitreal corticosteroid................................................. 156
Intravitreal dexamethasone implant.............................. 331
Intravitreal injection.................................................. 115,205
Intravitreal ranibizumab................................................... 243
Iris......................................................................................... 231
Juxtafoveal telangiectasia................................................ 144
Keratoconus........................................................................ 255
Lacrimal gland.................................................................... 165
Lagophthalmos.................................................................. 149
Latent tuberculosis............................................................... 89
Limbal stem cell deficiency.............................................. 285
Local anesthesia toxicity syndrome............................... 320
Low vision........................................................................... 216
Low vision aids................................................................... 216
Macula................................................................................... 28
Macular buckle................................................................... 351
Macular edema.......................................................... 110,331
Macular hole............................................................... 138,351
Macular telangiectasia type-2......................................... 279
Mantle cell lymphoma...................................................... 235
Measurement...................................................................... 247
Melanoma........................................................................... 231
Microtropia............................................................................ 74
Molluscum contagiosum.................................................. 226
Morphological changes..................................................... 255
Multifocal serpiginoid choroiditis...................................... 89
Multispot lasers..................................................................... 34
Nephropathy....................................................................... 292
Neuroretinitis............................................................................ 9
Non-contact tonometry......................................................... 1
Nystagmus........................................................................... 211
Ocular................................................................................... 211
Ocular barotrauma............................................................ 296
Open globe injury................................................................. 18
Ophthalmologist................................................................. 320
Ophthalmoplegia................................................................ 235
Ophthoselfie........................................................................ 130
Optic coherence tomography........................................... 267
Optic coherence tomography angiography................... 279
Optic neuropathy.................................................................... 9
Optic pit.................................................................................. 56
Optic pit maculopathy......................................................... 56
Optical.................................................................................. 231
Optical coherence tomography........... 28,59,119,261,298, 306,315,326
Orbit.............................................................................. 113,165
Pain....................................................................................... 113
Patient compliance............................................................ 205
Pediatric............................................................................... 247
Pediatric intraocular pressure................................................ 1
Pencil lead.............................................................................. 52
Penetrating keratoplasty..................................................... 63
Photopic................................................................................. 80
Pigment epithelial detachment........................................ 133
Polycystic ovary syndrome................................................ 24
Polypoidal choroidal vasculopathy................................ 355
Posterior polar central choroidal dystrophy.................. 298
Posterior uveitis................................................................... 110
Prevention............................................................................ 296
Primary open-angle glaucoma......................................... 198
Proptosis......................................................................... 94,174
Pseudoexfoliation.............................................................. 106
Pseudoexfoliation syndrome................................................ 5
Psoriasis.................................................................................. 42
Ptosis..................................................................................... 113
Purtscher retinopathy........................................................ 348
Purtscher-like retinopathy................................................. 348
Radiotherapy........................................................................ 94
Ranibizumab.............................................................. 115,205
Recalcitrant......................................................................... 274
Renal cell carcinoma......................................................... 180
Retina..................................................................................... 59
Retinal angiomatous proliferation.................................. 355
Retinal artery occlusion....................................................... 59
Retinal detachment........................................................... 351
Retinal hemangioblastoma.............................................. 180
Retinal infiltrate...................................................................... 9
Retinal nerve fiber layer.............................................. 28,267
Retinal nerve fiber layer.................................................... 326
Retinal nerve fiber layer thickness.................................. 192
Retinal vein occlusion....................................................... 331
Retinoschisis........................................................................ 119
Rheumatoid arthritis.................................................. 125,315
Rituximab.............................................................................. 42
Sarcoidosis........................................................................... 165
Scleral thickness................................................................. 315
Selective laser trabeculoplasty......................................... 198
Selfie..................................................................................... 130
Serpiginous choroiditis......................................................... 89
Sesamol................................................................................ 309
Side effects............................................................................ 34
Sixth nerve palsy.................................................................. 47
Sodium selenite................................................................... 309
Spectral domain optic coherence tomography..... 279,302
Specular microscopy......................................................... 255
Spontaneous regression....................................................... 56
Staphylococcus epidermidis .............................................. 68
Stem cell transplantation.................................................. 285
Stenting ............................................................................... 192
Steroid therapy...................................................................... 94
Strabismus........................................................................... 211
Subconjunctival haemorrhage........................................ 296
Suborbicularis oculi fat pad............................................. 149
Subretinal neovascularization......................................... 144
Susac syndrome.................................................................... 59
Thrombotic microangiopathy.......................................... 348
Thyroid ophthalmopathy................................................... 94
Tomography....................................................................... 231
Tono-Pen tonometry.............................................................. 1
Tonometer........................................................................... 247
Topography......................................................................... 249
Transposition surgery........................................................... 47
Treatment.................................................................... 174,205
Triamcinolone acetonide.................................................. 156
Tuberculosis........................................................................ 169
Ultrasound biomicroscopy............................................... 186
Ultraviolet-A/riboflavin..................................................... 161
Unilateral keratoconus...................................................... 249
Uveal biocompatibility...................................................... 221
Uveitis................................................................................... 169
Valacyclovir........................................................................ 174
Visual acuity............................................................... 133,216
Visual function...................................................................... 80
Visual impairment................................................................ 18
Visually impaired............................................................... 216
Vitreomacular interface.................................................... 261
Vogt-Koyanagi-Harada disease...................................... 238
Von Hippel-Lindau syndrome......................................... 180
Work accident....................................................................... 18
Work-related eye injury....................................................... 18
X-linked juvenile retinoschisis.............................................302